000 02445cam  2200409zi 4500
0019.893236
003CaOODSP
00520221107173406
006m     o  d f      
007cr cn|||||||||
008201104t20212021oncad   obs  f000 0 eng d
020 |a9780660365596
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-206/2020E-PDF
24500|aReport on the enhanced surveillance of antimicrobial-resistant gonorrhea (ESAG) : |bresults from 2015 to 2017.
24617|aReport on the enhanced surveillance of antimicrobial-resistant gonorrhea (ESAG) – results from 2015-2017
264 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2021.
264 4|c©2021
300 |a1 online resource (iv, 46 pages) : |billustrations, graphs
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |a"February 2021."
500 |aCover title.
500 |aIssued also in HTML format.
500 |aIssued also in French under title: Rapport sur le système de surveillance accrue de la résistance de la gonorrhée aux antimicrobiens (SARGA) : résultats de 2015 à 2017.
504 |aIncludes bibliographical references (pages 35-38).
520 |a"In Canada and globally, rates of sexually transmitted infections (STI) continue to rise and remain a serious public health threat. Gonorrhea is the most commonly reported drug resistant STI and the second most common bacterial STI in Canada with over 29,000 cases reported in 2017. Worldwide, an estimated 87 million new cases of gonorrhea were reported in 2016"--Introduction, page 4.
650 0|aGonorrhea|zCanada|vStatistics.
650 0|aGonorrhea|xTreatment|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tRapport sur le système de surveillance accrue de la résistance de la gonorrhée aux antimicrobiens (SARGA) : |w(CaOODSP)9.893238
795 |tReport on the enhanced surveillance of antimicrobial-resistant gonorrhea (ESAG) : |b2014-2015|w(CaOODSP)9.870670
85640|qPDF|s2.09 MB|uhttps://publications.gc.ca/collections/collection_2021/aspc-phac/HP40-206-2020-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/diseases-conditions/2015-2017-report-enhanced-surveillance-antimicrobial-resistant-gonorrhea.html